DK1264603T3 - Anvendelse af L-polynukleotider til in vivo-billeddannelse - Google Patents

Anvendelse af L-polynukleotider til in vivo-billeddannelse

Info

Publication number
DK1264603T3
DK1264603T3 DK01114110.8T DK01114110T DK1264603T3 DK 1264603 T3 DK1264603 T3 DK 1264603T3 DK 01114110 T DK01114110 T DK 01114110T DK 1264603 T3 DK1264603 T3 DK 1264603T3
Authority
DK
Denmark
Prior art keywords
polynucleotides
vivo imaging
polynucleotide
vivo
imaging
Prior art date
Application number
DK01114110.8T
Other languages
English (en)
Inventor
Sven Klussmann
Britta Dr Wlotzka
Original Assignee
Noxxon Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noxxon Pharma Ag filed Critical Noxxon Pharma Ag
Application granted granted Critical
Publication of DK1264603T3 publication Critical patent/DK1264603T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DK01114110.8T 2001-06-10 2001-06-10 Anvendelse af L-polynukleotider til in vivo-billeddannelse DK1264603T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01114110A EP1264603B8 (en) 2001-06-10 2001-06-10 Use of L-polynucleotides for in vivo imaging

Publications (1)

Publication Number Publication Date
DK1264603T3 true DK1264603T3 (da) 2010-04-26

Family

ID=8177688

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01114110.8T DK1264603T3 (da) 2001-06-10 2001-06-10 Anvendelse af L-polynukleotider til in vivo-billeddannelse

Country Status (6)

Country Link
EP (1) EP1264603B8 (da)
AT (1) ATE452655T1 (da)
AU (1) AU2002331313A1 (da)
DE (1) DE60140863D1 (da)
DK (1) DK1264603T3 (da)
WO (1) WO2002100442A2 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2518475C (en) 2003-03-07 2014-12-23 Alnylam Pharmaceuticals, Inc. Irna agents comprising asymmetrical modifications
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
US9267937B2 (en) 2005-12-15 2016-02-23 Massachusetts Institute Of Technology System for screening particles
US8367113B2 (en) 2006-05-15 2013-02-05 Massachusetts Institute Of Technology Polymers for functional particles
WO2007150030A2 (en) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
US9217129B2 (en) 2007-02-09 2015-12-22 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
US20090074828A1 (en) 2007-04-04 2009-03-19 Massachusetts Institute Of Technology Poly(amino acid) targeting moieties
MX2010003642A (es) 2007-10-12 2010-08-09 Massachusetts Inst Technology Nanotecnologia de vacuna.
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
CN107029223A (zh) 2010-05-26 2017-08-11 西莱克塔生物科技公司 合成纳米载体联合疫苗
DE102010056610A1 (de) * 2010-12-31 2012-07-05 Volker A. Erdmann Pharmazeutische Zusammensetzung enthaltend L-DNA
WO2012095303A1 (en) * 2011-01-10 2012-07-19 Noxxon Pharma Ag Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
CN112587671A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
EP3092256B1 (en) 2014-01-10 2022-05-18 Birdie Biopharmaceuticals Inc. Compounds and compositions for immunotherapy
DK4001311T3 (da) 2014-07-09 2026-02-02 Birdie Biopharmaceuticals Inc Anti-pd-l1/pd-1-kombinationer til behandling af tumorer
CN112546230A (zh) 2014-07-09 2021-03-26 博笛生物科技有限公司 用于治疗癌症的联合治疗组合物和联合治疗方法
CN112546238A (zh) 2014-09-01 2021-03-26 博笛生物科技有限公司 用于治疗肿瘤的抗-pd-l1结合物
US20180153884A1 (en) 2015-05-31 2018-06-07 Curegenix Corporation Combination compositions for immunotherapy
CN110559456B (zh) * 2019-10-28 2021-07-23 中国科学院武汉物理与数学研究所 一种19f-穴番纳米乳的磁共振成像显影剂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691981A1 (en) * 1993-03-10 1996-01-17 The Wellcome Foundation Limited Tumor targeting with l-enantiomeric oligonucleotide conjugates of immunoreagents and of chelated radionuclides
WO1996034879A1 (en) * 1995-05-03 1996-11-07 Whitehead Institute For Biomedical Research Identification of enantiomeric ligands
ES2188985T3 (es) * 1996-08-30 2003-07-01 Jens Peter Furste Seleccion enantiomerica y evolucion enantiomerica de acidos nucleicos.

Also Published As

Publication number Publication date
WO2002100442A2 (en) 2002-12-19
WO2002100442A3 (en) 2003-04-10
EP1264603A1 (en) 2002-12-11
AU2002331313A1 (en) 2002-12-23
EP1264603B8 (en) 2010-03-03
DE60140863D1 (de) 2010-02-04
EP1264603B1 (en) 2009-12-23
ATE452655T1 (de) 2010-01-15

Similar Documents

Publication Publication Date Title
DK1443955T3 (da) PDGF-BB til behandling af Parkinsons sygdom
DE60140863D1 (de) Verwendung von L-Polynukleotiden zur diagnostischen Bilderzeugung
DE60209785D1 (de) Gipszusammensetzung mit verbesserter deformationsstabilität
BR0216099B1 (pt) "conjunto de desgaste".
BR0101769B1 (pt) vestimenta descartável.
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
BR0201972B1 (pt) montante de suspensão.
NO20035314L (no) Ammunisjon med dobbelt kjerne
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
PT1389213E (pt) Formulacoes de 3,7-diazabiciclo 3,3,1¿ como compostos antiarritmicos
DK1262236T3 (da) Fremgangsmåde til fremstilling af formet legeme af alfa-alumina
DE60202489D1 (de) Lysin enthaltende kautablette
ATE337322T1 (de) Isoxazolin-derivate als antidepressiva
ITTO20020005A1 (it) Motociclo.
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
BR8103051Y1 (pt) bicicleta infantil.
FR2825006B3 (fr) Semelle chauffante
ES1048629Y (es) Forjado alveolar ligero.
EP1453813A4 (en) IMPROVED PURIFICATION OF 4,4- (5 -) - DI-t-BUTYL CYCLO HEXANO-18-KRONE-6
FR2824665B1 (fr) Photodetecteur de type cmos
ES1048400Y (es) Bota-patin mejorada.
DK1274677T3 (da) Fremgangsmåde til fremstilling af oximethere
ITTO20020348A0 (it) Motociclo.